FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078757530> ?p ?o ?g. }

• W2078757530 endingPage "1468" @default.
• W2078757530 startingPage "1458" @default.
• W2078757530 abstract "Minocycline protects against asthma independently of its antibiotic function and was recently reported as a potent poly(ADP-ribose) polymerase (PARP) inhibitor. In an animal model of asthma, a single administration of minocycline conferred excellent protection against ovalbumin-induced airway eosinophilia, mucus hypersecretion, and Th2 cytokine production (IL-4/IL-5/IL-12(p70)/IL-13/GM-CSF) and a partial protection against airway hyperresponsiveness. These effects correlated with pronounced reduction in lung and sera allergen-specific IgE. A reduction in poly(ADP-ribose) immunoreactivity in the lungs of minocycline-treated/ovalbumin-challenged mice correlated with decreased oxidative DNA damage. The effect of minocycline on PARP may be indirect, as the drug failed to efficiently block direct PARP activation in lungs of N-methyl-N'-nitro-N-nitroso-guanidine-treated mice or H(2)O(2)-treated cells. Minocycline blocked allergen-specific IgE production in B cells potentially by modulating T cell receptor (TCR)-linked IL-4 production at the mRNA level but not through a modulation of the IL-4-JAK-STAT-6 axis, IL-2 production, or NFAT1 activation. Restoration of IL-4, ex vivo, rescued IgE production by minocycline-treated/ovalbumin-stimulated B cells. IL-4 blockade correlated with a preferential inhibition of the NF-κB activation arm of TCR but not GSK3, Src, p38 MAPK, or ERK1/2. Interestingly, the drug promoted a slightly higher Src and ERK1/2 phosphorylation. Inhibition of NF-κB was linked to a complete blockade of TCR-stimulated GATA-3 expression, a pivotal transcription factor for IL-4 expression. Minocycline also reduced TNF-α-mediated NF-κB activation and expression of dependent genes. These results show a potentially broad effect of minocycline but that it may block IgE production in part by modulating TCR function, particularly by inhibiting the signaling pathway, leading to NF-κB activation, GATA-3 expression, and subsequent IL-4 production." @default.
• W2078757530 created "2016-06-24" @default.
• W2078757530 creator A5002404511 @default.
• W2078757530 creator A5004037751 @default.
• W2078757530 creator A5017098006 @default.
• W2078757530 creator A5022836469 @default.
• W2078757530 creator A5026357120 @default.
• W2078757530 creator A5026862511 @default.
• W2078757530 creator A5032410036 @default.
• W2078757530 creator A5032691554 @default.
• W2078757530 creator A5057786874 @default.
• W2078757530 creator A5061779391 @default.
• W2078757530 creator A5073400005 @default.
• W2078757530 creator A5079091531 @default.
• W2078757530 creator A5080444742 @default.
• W2078757530 creator A5082208073 @default.
• W2078757530 creator A5091510144 @default.
• W2078757530 date "2013-01-01" @default.
• W2078757530 modified "2023-10-14" @default.
• W2078757530 title "Minocycline Blocks Asthma-associated Inflammation in Part by Interfering with the T Cell Receptor-Nuclear Factor κB-GATA-3-IL-4 Axis without a Prominent Effect on Poly(ADP-ribose) Polymerase" @default.
• W2078757530 cites W1555985183 @default.
• W2078757530 cites W1859203717 @default.
• W2078757530 cites W1947221834 @default.
• W2078757530 cites W1979288156 @default.
• W2078757530 cites W1981575902 @default.
• W2078757530 cites W1993426597 @default.
• W2078757530 cites W1993479746 @default.
• W2078757530 cites W2004572321 @default.
• W2078757530 cites W2011668019 @default.
• W2078757530 cites W2014636672 @default.
• W2078757530 cites W2022188895 @default.
• W2078757530 cites W2023276714 @default.
• W2078757530 cites W2026028987 @default.
• W2078757530 cites W2027215365 @default.
• W2078757530 cites W2031593710 @default.
• W2078757530 cites W2032783440 @default.
• W2078757530 cites W2034545406 @default.
• W2078757530 cites W2039331633 @default.
• W2078757530 cites W2040768738 @default.
• W2078757530 cites W2045463226 @default.
• W2078757530 cites W2046341270 @default.
• W2078757530 cites W2050237494 @default.
• W2078757530 cites W2052946998 @default.
• W2078757530 cites W2053942643 @default.
• W2078757530 cites W2055443384 @default.
• W2078757530 cites W2055505026 @default.
• W2078757530 cites W2057227788 @default.
• W2078757530 cites W2062747680 @default.
• W2078757530 cites W2065295111 @default.
• W2078757530 cites W2070973756 @default.
• W2078757530 cites W2073580835 @default.
• W2078757530 cites W2077926137 @default.
• W2078757530 cites W2082700112 @default.
• W2078757530 cites W2089432079 @default.
• W2078757530 cites W2093713190 @default.
• W2078757530 cites W2106758558 @default.
• W2078757530 cites W2117753922 @default.
• W2078757530 cites W2118340286 @default.
• W2078757530 cites W2122276247 @default.
• W2078757530 cites W2133771754 @default.
• W2078757530 cites W2136837706 @default.
• W2078757530 cites W2146030797 @default.
• W2078757530 cites W2147119127 @default.
• W2078757530 cites W2148339508 @default.
• W2078757530 cites W2150668026 @default.
• W2078757530 cites W2154159315 @default.
• W2078757530 cites W2165096527 @default.
• W2078757530 cites W2167538584 @default.
• W2078757530 cites W2171089276 @default.
• W2078757530 doi "https://doi.org/10.1074/jbc.m112.419580" @default.
• W2078757530 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3548459" @default.
• W2078757530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23184953" @default.
• W2078757530 hasPublicationYear "2013" @default.
• W2078757530 type Work @default.
• W2078757530 sameAs 2078757530 @default.
• W2078757530 citedByCount "21" @default.
• W2078757530 countsByYear W20787575302013 @default.
• W2078757530 countsByYear W20787575302014 @default.
• W2078757530 countsByYear W20787575302015 @default.
• W2078757530 countsByYear W20787575302016 @default.
• W2078757530 countsByYear W20787575302017 @default.
• W2078757530 countsByYear W20787575302019 @default.
• W2078757530 countsByYear W20787575302021 @default.
• W2078757530 countsByYear W20787575302022 @default.
• W2078757530 countsByYear W20787575302023 @default.
• W2078757530 crossrefType "journal-article" @default.
• W2078757530 hasAuthorship W2078757530A5002404511 @default.
• W2078757530 hasAuthorship W2078757530A5004037751 @default.
• W2078757530 hasAuthorship W2078757530A5017098006 @default.
• W2078757530 hasAuthorship W2078757530A5022836469 @default.
• W2078757530 hasAuthorship W2078757530A5026357120 @default.
• W2078757530 hasAuthorship W2078757530A5026862511 @default.
• W2078757530 hasAuthorship W2078757530A5032410036 @default.
• W2078757530 hasAuthorship W2078757530A5032691554 @default.
• W2078757530 hasAuthorship W2078757530A5057786874 @default.
• W2078757530 hasAuthorship W2078757530A5061779391 @default.
• W2078757530 hasAuthorship W2078757530A5073400005 @default.
• W2078757530 hasAuthorship W2078757530A5079091531 @default.

• next